Cargando…

Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT Pathway

Hepatocellular carcinoma (HCC) as one of the most refractory cancers leads to high mortality worldwide. Long noncoding RNAs have been widely acknowledged as important biomarkers and therapeutic targets in HCC. In this study, we investigated the effects of long noncoding RNA FGFR3-AS1 on tumor growth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Juhua, He, Saifei, Wang, Guoyu, Wang, Guangdong, Ni, Jing, Zhang, Suiliang, Ye, Ying, Xia, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cognizant Communication Corporation 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844747/ https://www.ncbi.nlm.nih.gov/pubmed/29463348 http://dx.doi.org/10.3727/096504018X15172756878992

Ejemplares similares

MicroRNA-601 serves as a potential tumor suppressor in hepatocellular carcinoma by directly targeting PIK3R3
por: Song, Yanan, et al.
Publicado: (2022)

MicroRNA-495 suppresses cell proliferation and invasion of hepatocellular carcinoma by directly targeting insulin-like growth factor receptor-1
por: Ye, Ying, et al.
Publicado: (2022)

MicroRNA-511 Inhibits Cellular Proliferation and Invasion in Colorectal Cancer by Directly Targeting Hepatoma-Derived Growth Factor
por: He, Saifei, et al.
Publicado: (2018)

MicroRNA-302a-3p suppresses hepatocellular carcinoma progression by inhibiting proliferation and invasion
por: Ye, Ying, et al.
Publicado: (2018)

The Oncogenic Role of Tribbles 1 in Hepatocellular Carcinoma Is Mediated by a Feedback Loop Involving microRNA-23a and p53
por: Ye, Ying, et al.
Publicado: (2017)

MicroRNA-497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3
por: Zhuang, Juhua, et al.
Publicado: (2017)

MicroRNA-497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3
por: Zhuang, Juhua, et al.
Publicado: (2022)

ARHGAP24 regulates cell ability and apoptosis of colorectal cancer cells via the regulation of P53
por: Zhang, Suiliang, et al.
Publicado: (2018)

MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression
por: Ye, Ying, et al.
Publicado: (2017)

Combined effects of Lenvatinib and iodine-131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress
por: Wang, Guoyu, et al.
Publicado: (2018)

MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression
por: Ye, Ying, et al.
Publicado: (2022)

Long Noncoding RNA CCAL Promotes Papillary Thyroid Cancer Progression by Activation of NOTCH1 Pathway
por: Ye, Ying, et al.
Publicado: (2018)

microRNA-605 promotes cell proliferation, migration and invasion in non-small cell lung cancer by directly targeting LATS2
por: Ye, Ying, et al.
Publicado: (2022)

MiR‐3116 sensitizes glioma cells to temozolomide by targeting FGFR1 and regulating the FGFR1/PI3K/AKT pathway
por: Kong, Shiqi, et al.
Publicado: (2020)

NEIL3 contributes toward the carcinogenesis of liver cancer and regulates PI3K/Akt/mTOR signaling
por: Wang, Weichen, et al.
Publicado: (2021)

FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention
por: Wang, Yijun, et al.
Publicado: (2021)

MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway
por: Lv, Zhongzhe, et al.
Publicado: (2019)

PI3K/Akt/mTOR Signaling Pathway and the Biphasic Effect of Arsenic in Carcinogenesis
por: Chen, Qiao Yi, et al.
Publicado: (2018)

ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway
por: Ni, Sheng, et al.
Publicado: (2020)

Mahuang Decoction Attenuates Airway Inflammation and Remodeling in Asthma via Suppression of the SP1/FGFR3/PI3K/AKT Axis
por: Wei, Lina, et al.
Publicado: (2022)

Presence of both alterations in FGFR/FGF and PI3K/AKT/mTOR confer improved outcomes for patients with metastatic breast cancer treated with PI3K/AKT/mTOR inhibitors
por: Wheler, Jennifer J., et al.
Publicado: (2016)

Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway
por: Huang, Lu, et al.
Publicado: (2022)

MicroRNA-761 Targets FGFR1 to Suppress the Malignancy of Osteosarcoma by Deactivating PI3K/Akt Pathway [Retraction]
Publicado: (2021)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Sun, Eun Jin, et al.
Publicado: (2021)

GINS2 affects cell viability, cell apoptosis, and cell cycle progression of pancreatic cancer cells via MAPK/ERK pathway
por: Zhang, Miao, et al.
Publicado: (2020)

Aberrant expression of PI3K/AKT signaling is involved in apoptosis resistance of hepatocellular carcinoma
por: Wang, Zhuangqiang, et al.
Publicado: (2021)

PI3K/Akt signalling pathway-associated long noncoding RNA signature predicts the prognosis of laryngeal cancer patients
por: Nie, Qian, et al.
Publicado: (2023)

Erratum to “Tollip promotes hepatocellular carcinoma progression via PI3K/AKT pathway”
por: Huang, Lu, et al.
Publicado: (2022)

GPD1 inhibits the carcinogenesis of breast cancer through increasing PI3K/AKT-mediated lipid metabolism signaling pathway
por: Xia, Zhengchao, et al.
Publicado: (2023)

The ethyl acetate extract of Wenxia Changfu Formula inhibits the carcinogenesis of lung adenocarcinoma by regulating PI3K-AKT signaling pathway
por: Wang, Lei, et al.
Publicado: (2023)

PI3K/AKT/mTOR Signaling Pathway in HPV-Driven Head and Neck Carcinogenesis: Therapeutic Implications
por: Aguayo, Francisco, et al.
Publicado: (2023)

NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling
por: Gong, Chengwu, et al.
Publicado: (2019)

The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
por: Tian, Ling-Yu, et al.
Publicado: (2023)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

GINS2 affects cell proliferation, apoptosis, migration and invasion in thyroid cancer via regulating MAPK signaling pathway
por: He, Saifei, et al.
Publicado: (2021)

PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer
por: Zhuang, Juhua, et al.
Publicado: (2019)

Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma
por: Wang, Houhong, et al.
Publicado: (2023)

TRMT6 promotes hepatocellular carcinoma progression through the PI3K/AKT signaling pathway
por: Ye, Yanqing, et al.
Publicado: (2023)

HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway
por: Wang, Meng, et al.
Publicado: (2020)

Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation
por: Wang, Xicheng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f7l897hg25lj7jrrjnerbbur4t